• YAKHAK HOEJI
• /
• v.41 no.3
• /
• pp.312-320
• /
• 1997

Pharmacokinetics and tissue distribution of DWP20349 and 20351, new quinolones, were examined in rats after a single intravenous and oral administration. Analyses of DWP20349 an d DWP20351 in plasma, tissue, and urine were determined by both HPLC and bioassay(microbiological assay). The plasma concentrations of the drugs declined biexponentially. The terminal half-lives ($t_{1/2\beta}$) of drugs were about 114 min (DWP20349) and 105 min (DWP20351) after intravenous dosing, and were 77 min (DWP20349) and 79 min (DWP20351) after oral dosing. The volume of distrbution at steady-state ($Vd_{ss}$) and total body clearances ($Cl_t$) of DWP20349 and DWP20351 were 760 ml/kg and 1126 ml/kg, and 5ml/min/kg and 10 ml/min/kg, respectively. The extents of bioavailability if DWP20349 and DWP20351 after oral administration were 29% and 28%, respectively. 24 h urinary recoveries measured by bioassay were 1.8% (DWP20349) and 1.3% (DWP20351) after oral dosing, and 2.4% (DWP20349) and 1.9% (DWP20351) after intravenous dosing. Plasma protein binding ratios ranged from 87%-90% (DWP20349) and 61%-68% (DWP20351). These drugs were highly distrbuted by the order of lung, kidney, liver and plasma (DWP20394), and lung, liver, kidney and plasma (DWP20351) after 1 hour orally administered.

• Journal of Food Hygiene and Safety
• /
• v.13 no.1
• /
• pp.14-19
• /
• 1998

The residual tissue concentraion of the widely used aquatic antibacterial agent, oxolinic acid, was surveyed in eels collected from fish markets of Chonbuk Province, Korea. Their concentrations in the dorsolateral muscle were widely varying. In about 32% of samples examined, oxolinic acid was not detected. In about 16% of those samples in which oxolinic acid was detected, the concentration was above 0.1 ppm. The tissue distrubution of the agent in major organs was in the rank order of kidney>liver>plasma>muscle. When the muscle samples which contained residual oxolinic acid were baked for up to 10 min, there was no change in the drug concentration. Their concentration declined to about 50% by baking for 30 min at which time the tissue turned to the texture of charcoal. The extreme stability of oxolinic acid to heating process was confirmed with muscle samples from eels to which a high dose of oxolinic acid was administered, and also with an aqueous oxolinic acid solution of known concentration. It is suggested that an effective regulatory measure should be initiated to keep eel consumers from residual oxolinic acid impact.